Editor
Home health company Amedisys said Monday it has agreed to be acquired by UnitedHealth Group’s Optum in an all-cash transaction for $101 per share.
The bid is higher than Optum’s original offer in early June of $100 per share, or $3.3 billion, for the Baton Rouge, Louisiana-based company.
Home infusion company Option Care Health, which announced plans in early May to buy Amedisys for $3.6 billion in stock, said in a news release it ended…
